PLUS THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 6Avg age 64Avg tenure 6.5y
MH
Marc Hedrick
Chief Executive Officer
Age 64Since 2014-04-01Profile →
+10
Executives5
MH
Marc Hedrick→
Chief Executive Officer
Age 64Since 2014-04-01
AS
Andrew Sims→
Director of Finance/CFO
Age 52Since 2020-02-05
DO
Daniel Ortega
Chief Tech/Sci/R&D Officer
—Since 2025-10-20
ED
Eric Daniels
Corporate Officer/Principal
Age 53Since 2026-04-19
RH
Russ Havranek
Corporate Officer/Principal
——
Board of directors6
MH
Marc Hedrick→
Director/Board Member
Age 64Since 2002-09-30
RH
Richard Hawkins→
Chairman
Age 77Since 2018-01-24
AE
An van Es-Johansson→
Director/Board Member
Age 66Since 2019-12-31
JC
J. Clowes→
Director/Board Member
Age 72Since 2020-02-29
KG
Kyle Guse→
Director/Board Member
Age 62Since 2025-04-17
RA
Ronald Andrews→
Director/Board Member
Age 66Since 2026-03-19
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Heights Capital Management, Inc. | 7.21 % | 494,737 |
| Vanguard Capital Management LLC | 1.415 % | 97,084 |
| Geode Capital Management LLC | 1.175 % | 80,653 |
| BlackRock Institutional Trust Co. NA | 1.035 % | 71,055 |
| S.H.N. Financial Investments Ltd. | 0.8744 % | 60,000 |
Catalog · 2026-07-09
Registry officers7
| Name | Role | Since | Shares |
|---|---|---|---|
| Andrew Sims | Chief Financial Officer Non-Employee Directors Howard Clowes (1)(2)(3) 71 Director An van Es-Johansson, MD (1)(3) 65 | — | - |
| Richard Hawkins | Chairman | 2018-01-24 | - |
| An van Es-Johansson | Director/Board Member | 2019-12-31 | - |
| J. Clowes | Director/Board Member | 2020-02-29 | - |
| Kyle Guse | Director/Board Member | 2025-04-17 | - |
| Marc Hedrick | Director/Board Member | 2002-09-30 | - |
| Ronald Andrews | Director/Board Member | 2026-03-19 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 36Range 12–57Analysts 4
12Mean 3657
- Strong buy 1
- Buy 3
Broker actions37
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | 57 | 2026-06-08 |
| Ascendiant Capital | Maintained | Buy | 65 | 2026-04-09 |
| D. Boral Capital | Downgrade | Hold | — | 2026-03-31 |
| D. Boral Capital | Maintained | Buy | 3 | 2026-03-19 |
| HC Wainwright & Co. | Maintained | Buy | 1 | 2026-01-23 |
| D. Boral Capital | Maintained | Buy | 4 | 2026-01-22 |
| D. Boral Capital | Maintained | Buy | 5 | 2026-01-08 |
| D. Boral Capital | Maintained | Buy | 5 | 2025-12-11 |
| D. Boral Capital | Maintained | Buy | 5 | 2025-12-01 |
| Ascendiant Capital | Maintained | Buy | 19 | 2025-11-21 |
| D. Boral Capital | Maintained | Buy | 5 | 2025-11-20 |
| HC Wainwright & Co. | Maintained | Buy | 2 | 2025-11-03 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.